Repligen Stock Analysis

Repligen Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The book value of Repligen was at this time reported as 35.17. The company has Price/Earnings To Growth (PEG) ratio of 2.59. Repligen recorded a loss per share of 0.46. The entity last dividend was issued on the 29th of October 2010. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Repligen operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1852 people. To find out more about Repligen contact Anthony Hunt at 781 250 0111 or learn more at https://www.repligen.com.

Repligen Investment Alerts

Repligen Upcoming and Recent Events

Repligen Largest EPS Surprises

View All Earnings Estimates

Repligen Environmental, Social, and Governance (ESG) Scores

Repligen Stock Institutional Investors

Note, although Repligen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Repligen Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.1 B.

Repligen Profitablity

The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.

Management Efficiency

As of the 20th of March 2025, Return On Tangible Assets is likely to drop to -0.0095. In addition to that, Return On Capital Employed is likely to drop to -0.01. At this time, Repligen's Intangible Assets are very stable compared to the past year. As of the 20th of March 2025, Net Tangible Assets is likely to grow to about 847.1 M, while Deferred Long Term Asset Charges is likely to drop about 2.2 M. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 20th of March, Repligen holds the Variance of 9.62, insignificant risk adjusted performance, and Coefficient Of Variation of (10,432). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repligen, as well as the relationship between them.

Repligen Price Movement Analysis

Repligen Insider Trading Activities

Repligen Outstanding Bonds

Repligen Predictive Daily Indicators

Repligen Corporate Filings

Repligen Forecast Models

Repligen's time-series forecasting models are one of many Repligen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Repligen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Repligen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Repligen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Repligen. By using and applying Repligen Stock analysis, traders can create a robust methodology for identifying Repligen entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Repligen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Repligen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Repligen stock analysis indicators help investors evaluate how Repligen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Repligen shares will generate the highest return on investment. By understating and applying Repligen stock analysis, traders can identify Repligen position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.